Items where Author is "<span class="person_name">Murnane, D.</span>"
Number of items: 8.
Assessment of a cyclone-type spacer device for use in dry powder inhalation. (2013)
I. Parisini,
S. J. Cheng,
D. D. Symons,
Marc Brown,
A. Kostrzewski
and
D. Murnane
The effect of aerodynamic particle size and solid state disorder on salmeterol xinafoate deposition from pressurised metered dose and dry powder inhaler formulations. (2013)
S. Jaffari,
G. Sandhu,
G. P. Martin,
B. Forbes,
E. Collins
and
D. Murnane
Formation and measurement of process induced disorder during the manufacture of inhalation medicines. (2011)
P.G. Royall,
B. Woodhead,
S.J. Tang,
G.P. Martin,
B.M. Stockton
and
D. Murnane
Characterization of latent heat-releasing phase change materials for dermal therapies. (2011)
D.G. Wood,
Marc Brown,
S. A. Jones
and
D. Murnane
Transiently supersaturated solutions from the dissolution of amorphous powders for topical drug delivery. (2010)
I. A. Palmer,
S. A. Jones,
D. Murnane,
M.J. Traynor,
Gary Moss
and
Marc Brown
Evidence for flocculation-controlled microcrystallisation of salmeterol xinafoate. (2006)
D. Murnane,
G.P. Martin,
I. Haley
and
C. Marriott
Particle aggregation of salmeterol xinafoate (SX) in HFA134a high pressure suspensions. (2006)
D. Murnane,
G.P. Martin
and
C. Marriott
Investigation of a reverse-phase high performance liquid chromatography (RP-HPLC) method for a weakly basic drug. (2005)
D. Murnane,
G. P. Martin
and
C. Marriott